The physiology and pathophysiology of the nitric oxide/superoxide system

Herz

Volumn 22, Issue 3, 1997, Pages 158-172

  Munzel T ^a   Heitzer, T ^b   Harrison, D G ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

atherosclerosis; endothelium; nitrate tolerance; peroxinitrite; vitamin C

Indexed keywords

ASCORBIC ACID; NITRATE; NITRIC OXIDE; SUPEROXIDE;

ATHEROSCLEROSIS; ENDOTHELIUM; HUMAN; PATHOGENESIS; REVIEW;

EID: 0030737530     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044353     Document Type: Review

References (89)

1. Anderson, T. J., I. Meredith, A. C. Yeung, B. Frei, A. P. Selwyn, P. Ganz: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion [see comments]. New Engl. J. Med. 332 (1995).
2. Andrea, J. E., M. P. Walsh: Protein kinase C of smooth muscle. Hypertension 20 (1992,) 585-595.
3. Bauersachs, J., M. Hecker, R. Busse: Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450- derived arachidonic acid metabolite in the coronary microcirculation. Brit. J. Pharmacol. 113 (1994), 1548-1553.
4. Beckman, J. S., Z. Y. Ye, P. G. Anderson, J. Chen, M. A. Accavetti, M. M. Tarpey, C. R White: Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Hoppe-Seylers Z. physiol. Chem. 375 (1994), 81-88.
5. Bevilacqua, M. P.: Endothelial-leucocyte adhesion molecules. Ann. Rev. Immunol. 11 (1993), 767-804
6. Bolotina, V. M., S. Najibi, J. J. Palacino, P. J. Pagano, R. A. Cohen: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature (Lond.) 368 (1994), 850-853.
7. Cayette, A. J., J. J. Palacino, K. Horten, R. A. Cohen: Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterlosclcr. Thrombos. 14 (1994), 753-759.
8. Celermajer, D. S., K. E. Sorensen, V. M. Gooch, D. J. Spiegelhalter, O. I. Miller, I. D. Sullivan, J. K. Lloyd, J. E. Deanfleld: Non-invasive detection of endothchal dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992), 1111-1115.
9. Cox, D. A , J. A. Vita, C. B. Treasure, R. D. Fish, R. W. Alexander, P. Ganz, A. P. Selwyn: Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 80 (1989), 458-465.
10. Creager, M. A., J. P. Cooke, M. E. Mendelsohn, S. J. Gallagher, S. M. Coleman, J. Loscalzo, V. J. Dzau: Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. clin. Invest. 86 (1990,) 228-234.
11. Drexler, H., A. M. Zeiher, H. Wollschlaeger, T. Meinertz, H. Just, T. Bonzel: Flow-dependent coronary artery dilatation in humans. Circulation 80 (1989), 466-474.
12. Drexler, H., A. M. Zeiher, W. Köster, W. Zeh, H. Wieland: Endothelial dysfunction in Ihe coronary circulation in hypercholesterolemia: effect of high HDL-cholesterol. Circulation 86, Suppl. 1 (1992), 467.
13. Egashira, K., H. Y. Kai et al.: Reduction in serum cholesterol with provastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89 (1994), 2519-2524.
14. Feelisch, M., M. Keim: Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle cells and endothelial cells. Biochem. biophys. Res. Commun. 190 (1991), 286-293.
15. Feletou, M., P. M. Vanhoutte: Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Brit. J. Pharmacol. 93 (1988), 515-524.
16. Frei, B., L. England, B. N. Ames: Ascorbate is an outstanding antioxidant in human blood plasma. Proc. nat. Acad. Sci. (Wash.) 86 (1989), 6377-6381.
17. Frei, B., T. M. Forte, B. N. Ames, C. E. Cross: Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem. J. 277 (1991), 133-138.
18. Freiman, P. C., G. C. Mitchell, D. D. Heistad, M. L. Armstrong, D. G. Harrison: Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circulat. Res. 58 (1986,) 783-789.
19. Furchgott, R. F., J. V. Zawadzki: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.) 228 (1980), 373-376.
20. Garg, U. C., A. Hassid: Nitric oxide-generating vasodilators and 8bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. clin. Invest. 83 (1989), 1774-1777.
21. Gordon, J. B., P. Ganz, E. G. Nabel, R. D. Fish, J. Zebede, G. H. Mudge, R. W. Alexander, A. P. Selwyn: Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise J. clin. Invest. 83 (1989), 1946-1952.
22. Griendling, K. K., C A Minieri, J. D. Ollerenshaw, R. W. Alexander: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circulat. Res. 74 (1994), 1141-1148.
23. Gruetter, C. A., D. Y. Gruetter, J. E. Lyon, P. J. Kadowitz, L. J. Ignarro: Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J. Pharmacol. exp. Ther. 219 (1981), 181-186.
24. Gryglewski, R. J., R. M. J Palmer, S. Moncada: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (Lond.) 320 (1986), 454-456.
25. Gyllenhammar, H.: Lucigenin chemiluminescence in the assessment of neutrophil Superoxide production. J. immunol. Meth. 97 (1987.) 209-213.
26. Habib, J. B., C. Bossaller, S. Wells, C. Williams, J. D. Morrisett, P. D. Henry: Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Circulat. Res. 58 (1986), 305-309.
27. Harrison, D. G., M. L. Armstrong, P. C. Freiman, D. D. Heistad: Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J. clin. Invest. 80 (1987), 1808-1811.
28. Harrison, D. G., P. C. Freiman, M. L. Armstrong, M. L. Marcus, D. D. Heistad: Alterations of vascular reactivity in atherosclerosis. Circulat. Res. 61 (1987), II74-II80.
29. Harrison, D. G , P. J. Heald: The isolation of poly-alpha-L-glutamic acid from the oviduct of the domestic fowl. Proc. roy. Soc. Lond. B 166 (1966), 341-357.
30. Harrison, D. G.: Endothelial regulation of vasomotion: alterations in atherosclerosis. Canad. J. Cardiol. 9 (1993), 1A-6A.
31. Heistad, D. D., M. L. Armstrong, M. L. Marcus, D. J. Piegors, A. L. Mark: Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circulat. Res. 54 (1984) 711-718.
32. Heitzer, T., S Ylä-Herttuala, J. Luoma, S. Kurz, T. Münzel, H. Just, M. Olschewski, H. Drexler: Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation 93 (1996), 1346-1353.
33. Heitzer, T., H. Just, T. Münzel: Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94 (1996), 6-9.
34. Henry, P. D., M. Yokoyama: Supersensitivity of atherosclerotic rabbit aorta to ergonovine: mediation by a serotonergic mechanism. J. clin. Invest. 66 (1980), 306-313.
35. Kifor, I., V. Dzau: Endothelial renin angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circulat. Res. 60 (1987), 422-428.
36. Kubes, P., M. Suzuki, D. N. Granger: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. nat. Acad. Sci. (Wash.) 88 (1991), 4651-4655.
37. Lamas, S., P. A. Marsden, G. K. Li, P. Tempst, T. Michel: Endothelial nitric oxide synthase: molecular cioning and characterization of a distinct constitutive enzyme isoform. Proc. nat. Acad. Sci. (Wash.) 89 (1992), 6348-6352
38. Lehr, H. A., B. Frei, A. M. Olofsson, T. E. Carew, K. E. Arfors: Protection from oxidized LDL-induced leucocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 91 (1995), 1525-1532.
39. Lerman, A., J. C. Burnett Jr: Intact and altered endothelium in regulation of vasomotion. Circulation 86 (1992), 1112-1119.
40. Lerman, A., M. W. Webster, J. H. Chesebro, W. D. Edwards, C. M. Wei, V. Fuster, J. C. Burnett Jr.: Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 88 (1993), 2923-2928.
41. Leung, W. H., L. C. Pak, C. K. Wong: Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 341 (1993), 1496-1500.
42. Levesque, M. J., R M. Nerem: The elongation and orientation of cultured endothelial cells in response to shear stress. J. Biomech. Eng. 107 (1985), 341-347.
43. Liew, F. Y., F. E. G. Cox: Nonspecific defence mechanism: the role of nitric oxide. Immunoparasitol. Today (1991).
44. Lin, L., A. Nasjiletti: Role of endothelium derived prostanoid in angiotensin induced vasoconstriction. Hypertension 18 (1991), 158-164.
45. Lincoln, T. M., P. Kornalavilas, T. L. Cornwell: Plelotropic regulation of vasoular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 23 (1994), 1141-1147.
46. Liu, S., J. S. Beekman, D. D. Ku: Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J. Pharmacol. exp. Ther. 268 (1994,) 1114-1121.
47. Ludmer, P. L., A. P. Selwyn, T. L. Shook, R. R. Wayne, G. H. Mudge, R. W. Alexander, P. Ganz: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. New Engl. J. Med. 315 (1986), 1046-1051.
48. Luscher, T. F., P. M. Vanhoutte: Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8 (1986), 344-348.
49. Luscher, T. F.: Endothelium in the control of vascular tone and growth: role of local mediators and mechanical forces. Blood Pressure I , Suppl. (1994,) 18-22.
50. Martin, W., G. M. Villani, D. Jothianandan, R. F. Furchgott: Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. exp. Ther. 232 (1985), 708-716.
51. Maseri, A.: Spasm and dynamic coronary stenoses. J. cardiovasc. Pharmacol. 6, Suppl. 4 (1984), S683-S690.
52. Matsubara, T., M. Ziff: Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J. cell. Physiol. 127 (1986), 207-210.
53. Minor, R. L., Jr., P. R. Myers, R. Guerra, Jr., J. N. Bates, D. G. Harrison: Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. clin. Invest. 86 (1990), 2109-2116.
54. Mohazzab-H., K. M., P. M. Kaminski, M. S. Wolin: NADH oxidoreductase is a major source of superoxide anion in bovine coronary endothelium. Amer. J. Physiol. 266 (1994), H2568-H2572.
55. Mugge, A., J. H. Elwell, T. E. Peterson, T. G. Hofmeyer, D. D. Heistad, D. G. Harrison: Chronic treatment with polyethylene-glycolated superoxide dism utase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circulat. Res. 69 (1991), 1293-1300.
56. Münzel, T., A. Giaid, S. Kurz, D. J. Stewart, D. G. Harrison: Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc. nat. Acad. Sci. (Wash.) 92 (1995), 5244-5248.
57. Münzel, T., S. Kurz, S. Rajagopalan, M. Thoenes, W. R. Berrington, J. A. Thompson, B. A. Freeman, D. G. Harrison: Hydralazine provents mtroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase:a new action for an old drug. J. clin. Invest. 98 (1996), 1465-1470.
58. Münzel, T., H. Sayegh, B. A. Freeman, M. M. Tarpey, D. G. Harrison: Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. clin. Invest. 95 (1995), 187-194.
59. Münzel, T., S. Kurz, S. Rajagopalan, M. Tarpey, B. Freeman, D. G. Harrison: Identification of the membrane bound NADH oxidase as the major source of superoxide anion in nitrate tolerance (abstract). Endothelium 3, Suppl. (1995), s14.
60. Münzel, T., T. Heitzer, S. Kurz, D. G. Harrison, C. Luhman, L. Pape, M. Olschewski, H. Just: Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. J. Amer. Coll. Cardiol. 27 (1996), 297-303.
61. Nabel, E. G., A. P. Selwyn, P. Ganz: Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation 81 (1990), 850-859.
62. Najibi, S., R. Cohen: Enhanced role of K+ channels in relaxations of hypercholesterolemic rabbit carotid artery to NO. Amer. J. Physiol. 269 (1995), H805-H811.
63. Nishida, K., D. G. Harrison, J. P. Navas, A. A. Fisher, S. P. Dockery, M. Uematsu, R. M. Nerem, R. W. Alexander, T. J. Murphy: Molecular cioning and characierization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. clin. Invest. 90 (1992), 2092-2096.
64. Niu, X. F., C. W. Smith, P. Kubes: Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circulat. Res. 74 (1994), 1133-1140.
65. Ohara, Y., T. E. Peterson, D. G. Harrison: Hypercholesterolemia increases endothelial superoxide anion production. J. clin. Invest. 91 (1993), 2546-2551.
66. Ohara, Y., T. E. Peterson, H. S. Sayegh, R. R. Subramanian, J. N. Wilcox, D. G. Harrison: Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 92 (1995), 898-903.
67. Packer, M., W. Lee, P. D. Kessler, S. S. Gottlieb, N. Medina, M. Yushak: Prevention and reversal of nitrate tolerance in patients with congestive heart fallure. New Engl. J. Med. 317 (1987), 799-804.
68. Palmer, R. M., A. G. Ferrige, S. Moncada: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (Lond.) 327 (1987), 524-526.
69. Radl, R., J. W. Beckman, K. M. Bush, B. A. Freeman: Peroxynitrite induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288 (1991), 481-487.
70. Radomski, M. W., R. M. J. Palmer, S. Moncada: Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Brit. J. Pharmacol. 92 (1987), 181-187.
71. Rajagopalan, S., S. Kurz, T Münzel, M. Tarpey, B. A. Freeman, K. K. Griendling, D. G. Harrison: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. clin. Invest. 97 (1996), 1916-1923.
72. Rapoport, R. M., M. B. Draznin, F Murad Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature (Lond.) 306 (1983), 174-176.
73. Retsky, K. L., M. W. Freeman, B. Frei: Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. J. biol. Chem. 268 (1993), 1304-1309.
74. Roth, A., D. Kulick, L. Freidenberger, R. Hong, S. H. Rahimtoola, U. Elkayam. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with ssvere chronic heart fallure. J. Amer. Coll. Cardiol. 9 (1987), 858-864.
75. Rubanyi, G. M., P. M. Vanhoutte: Oxygen-derived free radicals, endothelium and responsiveness of vascular smooth muscle. Amer. J. Physiol. 250 (1986), H815-H821.
76. Tagawa, H., H. Tomoike, W. Mitsuoka, S. Satoh, T. Kuga, H. Shimokawa, M. Nakamura, A. Takeshita: Hyperreactivity of aortic smooth muscle to serotonin is related to the presence of atheroma in Watanabe heritable hyperlipidaemic rabbits. Cardiovasc. Res. 27 (1993), 2164-2169.
77. Ting, H. H., F. K. Timimi, K. S. Boles, S. J. Creager, P. Ganz, M. A. Creager: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. clin. Invest. 97 (1996), 22-28.
78. Treasure, C. B., J. L. Klein, W. S. Weintraub: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease [see comments]. New Engl. J. Med. 332 (1995), 481-487.
79. Vita, J. A., C. B. Treasure, E. G. Nabel, J. M. McLenachan, R. D. Fish, A. C. Yeung, V. I. Vekshtein, A. P. Selwyn, P. Ganz: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81 (1990), 491-497.
80. Vita, J. A., C. B. Treasure, P. Ganz, D. A. Cox, R. D. Fish, A. P. Selwyn: Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis. J. Amer. Coll. Cardiol. 14 (1989,) 1193-1199.
81. Watt, G. F., B. Lewi, J. N. Brunt Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 339 (1992), 563-569.
82. White, C. R., T. A. Brock, L. Y. Chang, J. Crapo, P. Briscoe, D. Ku, W. A. Bradley, S. H. Gianturco, J. Gore, B. A. Freeman et al.: Superoxide and peroxynitrite in atheroselerosis. Proc. nat. Acad. Sci. (Wash.) 91 (1994), 1044-1048.
83. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, T. Masaki: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.) 332 (1988), 411-415.
84. Yeung, A. C., V. I. Vekshtein, D. S. Krantz, J. A. Vita, T. J. Ryan, P. Ganz, A. P. Selwyn: The effect of atherosolerosis on the vasomotor response of coronary arteries to mental stress. New Engl. J. Med. 325 (1991), 1551-1556.
85. Zeiher, A. M., H. Drexler, H. Wollschlaeger, B. Saurbier, H. Just: Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J. Amer. Coll. Cardiol. 14 (1989), 1181-1190.
86. Zhao, X. Q., B. G. Brown, L. Hillger: Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B. Circulation 88 (1993), 2744-2753.
87. Zierhut, W., H. A. Ball: Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C. Brit. J. Pharmacol. 119 (1996,) 3-5.
88. Zimrin, D., N. Reichek, K. T. Bogin, G. Aurigemma, P. Douglas, B. Berko, H. L. Fung: Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 77 (1988,) 1376-1384.
89. Pearson, J. D.: Baillers Clin. Haemat. 7 (1994), 441-452.